Zydus Cadila says ‘positive results’ from phase 2 studies of COVID-19 drug Desidustat in Mexico

Drug firm Zydus Cadila on Monday said it has received positive results from phase 2(b) studies of Desidustat in COVID-19 patients conducted in Mexico. In June 2020, Zydus Cadila had received approval from Mexico’s regulatory authority Cofepris to test one of its lead research candidates Desidustat in the management of COVID-19.




Read the Rest at INDIA TV

Leave a Reply

Your email address will not be published. Required fields are marked *